JASON HURT: Open Payments
NPI 1356325112 · BOWMAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$322 in 16 payments from 7 companies in 2025. Trend: 2023 $166 · 2024 $309 · 2025 $322
Food & beverage: $322
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $99 |
| ABBVIE INC. | 3 | $72 |
| Lilly USA, LLC | 3 | $54 |
| Otsuka America Pharmaceutical, Inc. | 1 | $32 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $32 |
| Exact Sciences Corporation | 1 | $19 |
| Novo Nordisk Inc | 1 | $15 |
Products named: AIRSUPRA, MOUNJARO, MAVYRET, REXULTI, CAPLYTA, VRAYLAR, The Cologuard Plus Collection Kit, BREZTRI.
Industry payments across GA — which companies pay providers there.
